Dyne Therapeutics Completes $402.5 Million Public Offering of Common Stock

Leila Ahmed North America Legal Chronicle
Tagged:

WilmerHale has advised Dyne Therapeutics. Cooley LLP has advised the underwriters. Dyne Therapeutics, Inc., a clinical-stage company specializing in therapies for genetically driven neuromuscular diseases, has…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here